Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

INTRODUCTION: To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. METHODS: This prespecified pooled analysis of three ra...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2013
Soggetti:
Urology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752932/
https://ncbi.nlm.nih.gov/pubmed/23692526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12194
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi